Skip to content

Clinical study on luqiyishen granules in treating chronic nephritis of spleen and kidney yang deficiency type

Clinical study on luqiyishen granules in treating chronic nephritis of spleen and kidney yang deficiency type

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000915
Enrollment
Unknown
Registered
2025-05-07
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic glomerulonephritis

Interventions

Trial Group:Western medicine on the basis of treatment given Luqi Yishen granule treatment(once a bag (10g) , three times a day)

Sponsors

Seventh People's Hospital of Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) meet the Western medicine diagnostic criteria for chronic glomerulonephritis (2) in line with the diagnostic criteria of traditional Chinese medicine belong to the spleen and kidney yang deficiency type (3) age 18-65 years regardless of gender (4) patients with complete medical records voluntarily participated in clinical trials and signed an informed consent form

Exclusion criteria

Exclusion criteria: (1) did not meet the diagnostic criteria of Chinese and Western medicine and inclusion criteria (2) under 18 or over 65 years of age (3) pregnant or lactating women (4) identify people who are allergic to the drugs in the treatment regimen (5) rule out asymptomatic proteinuria secondary chronic nephritis etc. (6) peritoneal dialysis or hemodialysis (7) diagnosis of patients with primary diseases of other systems (including heart liver kidney and hematopoietic system) (8) persons with mental illness (e.g. schizophrenia depression anxiety etc.)

Design outcomes

Primary

MeasureTime frame
Red blood cell count in urine;Urinary microalbumin;Urine UACR;24-hour urinary protein quantification;

Secondary

MeasureTime frame
Serum cystatin C;Qualitative analysis of occult blood in urine;Qualitative analysis of urinary protein;

Countries

China

Contacts

Public ContactWei Fan

Seventh People's Hospital of Shanghai

24882582@qq.com13701834885

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026